Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.11 (
CD10
)
9,792
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
There is increasing evidence that neuropeptides, including bombesin, may influence growth, angiogenesis, invasiveness, and metastasis in prostate cancer. One of the molecules tightly involved in the regulation of neuropeptide activity is the integral membrane glycoprotein
CD10
, or
neutral endopeptidase 24.11
. The pattern of
CD10
expression in hyperplastic and neoplastic conditions of the prostate gland has not been previously described. Immunohistochemical staining for
CD10
and high-molecular-weight cytokeratin was performed on 92 cases of paraffin-embedded tissue from needle-core biopsy specimens and prostatectomy specimens. Normal and hyperplastic acini showed strong and distinct membrane (apical and intercellular) and cytoplasmic
CD10
expression in basal and secretory cells. In contrast, no intercellular membrane or cytoplasmic staining of secretory cells was seen in any cases of adenocarcinoma with Gleason patterns 2 or 3. A subset of high-Gleason grade adenocarcinoma (patterns 4 and 5) displayed
CD10
expression in the secretory cells; those cases shared a distinct morphological pattern.
Prostatic intraepithelial neoplasia (PIN)
showed consistent absence of intercellular membrane and cytoplasmic
CD10
expression in the secretory cells, with preserved expression in basal cells. Interestingly, the basal cells in basal cell hyperplasia lacked
CD10
expression, and no expression was noted in the secretory cells in all cases examined. Atrophic acini and those associated with acute and chronic inflammation retained
CD10
expression. In conclusion, a consistent differential pattern of
CD10
expression was seen in basal cell hyperplasia, PIN, and adenocarcinoma, suggesting a role for
CD10
in the pathobiology of the prostate gland.
...
PMID:The pattern of CD10 expression in selected pathologic entities of the prostate gland. 1279 18